Pill Identifier App

Express 3

This page contains information on Express 3 for veterinary use.
The information provided typically includes the following:
  • Express 3 Indications
  • Warnings and cautions for Express 3
  • Direction and dosage information for Express 3

Express 3

This treatment applies to the following species:
Manufacturer: Boehringer Ingelheim

Bovine Rhinotracheitis-Virus Diarrhea Vaccine, Modified Live Virus

Express 3 Indications

For vaccination of healthy, susceptible cattle as an aid in the reduction of diseases caused by Bovine Rhinotracheitis (IBR) virus, and Bovine Virus Diarrhea (BVD) Types 1 and 2. This vaccine may be used in pregnant females or calves nursing pregnant females, provided the females were vaccinated pre-breeding according to label directions with any Express® FP vaccine.

Composition

This product contains IBR, BVD Type 1 (Singer 1a cytopathic) and Type 2 (296 cytopathic) modified live viruses.

Directions For Use

Rehydrate one bottle of modified live virus vaccine by aseptically adding one bottle of liquid diluent. Shake well and use immediately.

Dosage: Using aseptic technique, inject 2 mL subcutaneously in front of the shoulder and midway of the neck, away from the suprascapular lymph node. Calves vaccinated before 6 months of age should be revaccinated at 6 months. A 2 mL booster dose is recommended annually.

Precautions

Store out of direct sunlight at a temperature between 35-45°F (2-7°C). Avoid freezing. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Stressed cattle should not be vaccinated. Do not use in pregnant cows or calves nursing pregnant cows. Burn vaccine containers and all unused contents. Injection site swelling may occur. Anaphylactoid reactions may occur.

Antidote: Epinephrine.

Preservative: Neomycin.

Warnings

Animal inoculation only. Accidental injection to humans can cause serious local reactions. Contact a physician immediately if accidental injection occurs.

Note: It is possible that healthy appearing cattle can be persistently infected with or incubating virulent BVD virus at the time of vaccination. In view of these findings and suggested causes, BVD vaccine is contraindicated in persistently infected cattle and use should be limited only to healthy, immunocompetent, unstressed, nonpregnant cattle.

Contents: Five 10 or 50 dose vials of MLV vaccine and five 20 or 100 mL vials of liquid diluent.

Federal regulations prohibit the repackaging or sale of the contents of this carton in fractional units. Do not accept if seal is broken.

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.S.A.

U.S. Veterinary License No. 124

Code

 

Contents:

 

110-331

50 Doses/Rehydrate with 100 mL

This package contains one 50 dose vial of MLV vaccine and one 100 mL vial of sterile water diluent.

10304-01

110-331

5 x 50 Doses

Five 50 dose vials of MLV vaccine and five 100 mL vials of liquid diluent.

10306-01

NAC No.: 10281294

BOEHRINGER INGELHEIM VETMEDICA, INC.
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
Telephone:   800-325-9167
Fax:   816-236-2717
Website:   www.bevaccinesmart.com
    www.bi-vetmedica.com
    www.productionvalues.us
    www.prrsresearch.com
    www.thinkmetacam.com
    www.vetera-vaccines.com
    www.vetmedin-us.com
    www.yourdogsheart.com
Email:   info@productionvalues.us
Every effort has been made to ensure the accuracy of the Express 3 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web4)